Reviewing the molecular mechanisms which increase endometrial cancer (EC) risk in women with polycystic ovarian syndrome (PCOS): Time for paradigm shift?

Gynecologic Oncology

Volumn 131, Issue 2, 2013, Pages 489-492

  Shafiee, Mohamad N ^a,b   Chapman, Caroline ^c   Barrett, David ^c   Abu, Jafaru ^d   Atiomo, William ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d DEPARTMENT OF OBSTETRICS AND GYNAECOLOGY   (United Kingdom)

Author keywords

Endometrial cancer; Genomic; IGF; Metabolomics; PCOS

Indexed keywords

ACYLCARNITINE; ANDROGEN; COMPLEMENT COMPONENT C4A; CYCLOPHILIN A; ESTROGEN; ESTROGEN RECEPTOR; INSULIN; INSULIN RECEPTOR; LINOLEIC ACID; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; OLEIC ACID; OSTEOPONTIN; PROGESTERONE RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; SOMATOMEDIN C; STEARIC ACID; STEROID 17ALPHA MONOOXYGENASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSGELIN; VALINE; VASCULOTROPIN;

ANDROGEN SYNTHESIS; APOPTOSIS; CANCER RISK; DIABETES MELLITUS; DIET; ENDOMETRIUM CANCER; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLOMICS; MOLECULAR MECHANICS; NUCLEAR MAGNETIC RESONANCE; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; RISK FACTOR; STEROID METABOLISM; THECA CELL;

ENDOMETRIAL CANCER; GENOMIC; IGF; METABOLOMICS; PCOS;

ENDOMETRIAL NEOPLASMS; FEMALE; GENOMICS; HUMANS; METABOLOMICS; POLYCYSTIC OVARY SYNDROME;

EID: 84886085794     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.06.032     Document Type: Review

References (38)

1. Cancer Research UK UK Cancer Incidence (2010) and Mortality (2010) Summary December 2012
2. B. Macmahon Risk factors for endometrial cancer Gynecol Oncol 2 2-3 1974 122 129
3. Z. Haoula, M. Salman, and W. Atiomo Evaluating the association between endometrial cancer and polycystic ovary syndrome Hum Reprod 27 5 2012 1327 1331
4. P. Hardiman, O.C. Pillay, and W. Atiomo Polycystic ovary syndrome and endometrial carcinoma Lancet 361 9371 2003 1810 1812
5. A. Lupulescu Estrogen use and cancer risk: a review Exp Clin Endocrinol 101 1993 204 214
6. M. Esteller Epigenetic in cancer N Eng J Med 358 11 2008 1148 1159
7. K. Banno, I. Kisu, M. Yanokura, and K. Masuda Endometrial cancer and hypermethylation: regulation of DNA and MicroRNA by epigenetics Biochem Res Int 2012 2012 738274 10.1155/2012/738274
8. K. Garg, K. Shih, R. Barakat, Q. Zhou, A. Iasonos, and R.A. Soslow Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset Am J Surg Pathol 33 12 2009 1869 1877
9. A. Dunaif Insulin resistance and the polycystic ovarian syndrome: mechanism and implications for pathogenesis Endocr Rev 18 1997 774 800
10. G. Rubin, H.B. Petersen, N.C. Lee, E.F. Maes, P.A. Wingo, and S. Becker Estrogen replacement therapy and the risk of endometrial cancer: remaining controversies Am J Obstet Gynecol 162 1990 148 154
11. K. Marsh, and J. Brand-Miller The optimal diet for women with polycystic ovary syndrome? Br J Nutr 94 2 2005 154 165
12. M. Nagamani, E.V. Hannigan, T.V. Dinh, and C.A. Stuart Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer J Clin Endocrinol Metab 67 1 1988 144 148
13. S. Oyama, and T. Izutsu Cell cycle analysis of endometrial cancer cells in vitro treated with growth factor and steroid hormone Hum Cell 5 1992 363 371
14. J.F. Randolph, S. Kipersztok, and J.W. Ayers The effect of insulin on aromatase activity in isolated human endimetrial glands and stroma Am J Obstet Gynecol 157 1987 1534 1539
15. L.W. Cheung, B.T. Hennessy, and J. Li High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability Cancer Discov 1 2 2011 170 185
16. E.E. Sheets, J.C.M. Tsibris, N.I. Cook, S.D. Virgin, R.M. DeMay, and W.N. Spellacy In vitro binding of insulin and epidermal growth factor to human endometrium and endocervix Am J Obstet Gynecol 153 1985 60 65
17. M. Nagamani, C.A. Stuart, P.A. Dunhardt, and M.G. Doherty Specific binding sites for insulin and insulin-like growth factor I in human endometrial cancer Am J Obstet Gynecol 165 1991 1865 1871
18. F. Talavera, R.K. Reynolds, J.A. Roberts, and K.M. Menon Insulin-like growth factor I receptors in normal and neoplastic human endometrium Anticancer Res 50 1990 3019 3024
19. R.B. Lathi, A.P. Hess, and S. Tulac Dose-dependent insulin regulation of insulin-like growth factor binding protein-1 in human endometrial stromal cells is mediated by distinct signaling pathways J Clin Endocrinol Metab 2005 1599 1606
20. L. Giudice Endometrium in PCOS: implantation and predisposition to endocrine CA Best Pract Res Clin Endocrinol Metab 20 2 2006 235-44
21. V.H. Jongen, H. Hollema, A.G. van der Zee, J.G. Santema, and M.J. Heineman Ovarian stromal hyperplasia and ovarian vein steroid levels in relation to endometrioid endometrial cancer BJOG 7 2003 690 695
22. Y. Chen, Y. Wang, and M. Li Expression of apoptosis regulatory protein bcl-2 and bax in endometrium of polycystic ovary syndrome Zhonghua Fu Chan Ke Za Zhi 34 11 1999 652 654
23. C. Avellaira, A. Villavicencio, K. Bacallao, F. Gabler, P. Wells, and C. Romero Expression of molecules associated with tissue homeostasis in secretory endometria from untreated women with polycystic ovary syndrome Hum Reprod 21 12 2006 3116 3121
24. A. Villavicencio, K. Bacallao, F. Gabler, A. Fuentes, J. Albornoz, and A. Casals Reregulation of tissue homeostasis in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia Gynecol Oncol 104 2 2007 290 295
25. R. Zhang, Y. He, X. Zhang, B. Xing, Y. Sheng, and H. Lu Estrogen receptor-regulated microRNAs contribute to the BCL2/BAX imbalance in endometrial adenocarcinoma and precancerous lesions Cancer Lett 314 2 2012 155 165 [28]
26. R.A. Wild, M. Rizzo, and S. Clifton Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis Fertil Steril 95 2011 1073 1079
27. A. Georgiadi, and S. Kersten Mechanisms of gene regulation by fatty acids Adv Nutr 3 2 2012 127 134
28. W. Li, Y. Tai, J. Zhou, W. Gu, Z. Bai, and T. Zhou Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis Cell Cycle 11 12 2012 2348 2358
29. B. Knebel, O.E. Janssen, S. Hahn, S. Jacob, U. Nitzgen, and J. Haas Genetic variations in SREBP-1 and LXRα are not directly associated to PCOS but contribute to the physiological specifics of the syndrome Mol Biol Rep 39 6 2012 6835 6842
30. J.L. Griffin, and J.P. Shockcor Metabolic profiles of cancer cells Nat Rev Cancer 4 2004 551 561
31. M.M. Gaudet, R.T. Falk, R.D. Stevens, M.J. Gunter, J.R. Bain, and R.M. Pfeiffer Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study J Clin Endocrinol Metab 97 9 2012 3216 3223
32. A. Monge, M. Jagla, G. Lapouge, S. Sasorith, and M. Cruchant Unfaithfulness and promiscuity of a mutant androgen receptor in a hormone refractory prostate cancer Cell Mol Life Sci 63 2006 487 497
33. A. Vellaichamy, A. Sreekumar, J.R. Strahler, T. Rajendiran, and J. Yu Proteomic interrogation of androgen action in prostate cancer cells reveals roles of aminoacyl tRNA synthetases PLoS One 4 2009 e7075
34. A. Sreekumar, L.M. Poisson, T.M. Rajendiran, A.P. Khan, and Q. Cao Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 457 2009 910 914
35. L.S. Jennifer, J.S. Natalie, and E.S. Gail Clinical applications of metabolomics in oncology: a review 2009 Clin Cancer Res 15 2 2009 123 127
36. O.C. Pillay, A. Leonard, R. Catalano, A. Sharkey, and P. Hardiman Endometrial gene expression in women with polycystic ovarian syndrome Hum Reprod 20 Suppl. 1 2005 96 99
37. N. Galazis, Yik-Lam Pang, M. Galazi, Z. Haoula, R. Layfield, and R. Hammond Proteomic biomarkers of endometrial cancer risk in women with polycystic ovary syndrome (PCOS). A systematic review and biomarker database integration Gynecol Endocrinol 29 7 2013 638 644
38. T.F. Bathen, J. Krane, T. Engan, K.S. Bjerve, and D. Axelson Quantification of plasma lipids and apolipoproteins by use of proton NMR spectroscopy, multivariate and neural network analysis NMR Biomed 13 5 Aug 2000 271 288